Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer

被引：26

作者：

Chen, Kai-Lung ^{[1
]}

Lin, Chia-Chi ^{[2
,3
]}

Cho, Yung-Tsu ^{[1
]}

Yang, Che-Wen ^{[1
]}

Sheen, Yi-Shuan ^{[1
]}

Tsai, Hsiao-En ^{[4
]}

Chu, Chia-Yu ^{[1
]}

机构：

[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan S Rd, Taipei 10002, Taiwan

[2] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[3] Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10002, Taiwan

[4] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Surg, Hsin Chu City, Taiwan

来源：

JAMA DERMATOLOGY | 2016年 / 152卷 / 03期

关键词：

INHIBITORS;

D O I：

10.1001/jamadermatol.2015.4448

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：340 / 342

页数：4

共 5 条

[1]

Adachi Shino, 2011, Gan To Kagaku Ryoho, V38, P1453

[2] Dermatologic side effects associated with the epidermal growth factor receptor inhibitors [J].

Agero, Anna Liza C. ;

Dusza, Stephen W. ;

Benvenuto-Andrade, Cristiane ;

Busam, Klaus J. ;

Myskowski, Patricia ;

Halpern, Allan C. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) :657-670

[3] Nail toxicity associated with epidermal growth factor receptor inhibitor therapy [J].

Fox, Lindy P. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (03) :460-465

[4]

Lacouture ME, 2013, EXPERT REV ANTICANC, V13, P721, DOI [10.1586/era.13.30, 10.1586/ERA.13.30]

[5] Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer [J].

Liao, Bin-Chi ;

Lin, Chia-Chi ;

Yang, James Chih-Hsin .

CURRENT OPINION IN ONCOLOGY, 2015, 27 (02) :94-101

← 1 →